We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

26 hedge funds and large institutions have $12.9M invested in Tenax Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

13% more funds holding

Funds holding: 23 → 26 (+3)

3.26% more ownership

Funds ownership: 50.54% → 53.8% (+3.3%)

1% less capital invested

Capital invested by funds: $13.1M → $12.9M (-$184K)

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.2M
2
ACM
ADAR1 Capital Management
Texas
+$502K
3
Morgan Stanley
Morgan Stanley
New York
+$329K
4
Raymond James Financial
Raymond James Financial
Florida
+$8.69K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.11K

Top Sellers

Rank Fund Capital Flow
1
VA
VR Adviser
New York
-$634K
2
Citadel Advisors
Citadel Advisors
Florida
-$74K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$19.1K
4
UBS Group
UBS Group
Switzerland
-$16.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBP
26
Union Bancaire Privee
Switzerland
$5 – – –
1
2

TENX Hedge Fund Activity: Q2 2025 in Review

26 of the 7,599 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2025, worth a combined $12.9M — down 1.4% from $13.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new TENX positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, adding an estimated $1.2M. The largest seller was VR Adviser, cutting an estimated $634K.

  • 26 institutional investors held Tenax Therapeutics (TENX) as of Q2 2025, up from 23 in Q1 2025.
  • Funds reported $12.9M of Tenax Therapeutics stock for Q2 2025, down 1.4% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q2 2025 and 0 closed out, a net change of +3 holders.
  • The largest Tenax Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $1.2M added.
  • The largest Tenax Therapeutics seller in Q2 2025 was VR Adviser, an estimated $634K sold.

Based on aggregated 13F filings for Q2 2025.